Clinical Trials for Cytomegalovirus Infection

A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine

NCT ID: NCT04975893

Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections

NCT ID: NCT06334497

This clinical trial is studying a new treatment approach for patients who have a cytomegalovirus (CMV) infection after receiving a kidney transplant. The trial will test the effectiveness and safet...

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

NCT ID: NCT05683457

This clinical trial is studying an experimental vaccine called mRNA-1647, which is designed to prevent cytomegalovirus (CMV) infections in people who have recently received a stem cell transplant. ...

A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection

NCT ID: NCT04706923

This clinical trial is testing a new treatment called intravenous brincidofovir (BCV) for patients with adenovirus (AdV) infections and cytomegalovirus (CMV) infections. The goal is to find out if ...